Aleksandar Smokovski, MD, MEconSC’s Post

As you know, neurological disorders are the leading cause of disability and mortality globally and access to essential medicines for these disorders remains a critical global health challenge. On 23 July (14:00 CEST), World Health Organization will host a webinar to launch a report on Improving access to medicines for neurological disorders, comprehensively describing the status of access to these essential medicines globally. Using epilepsy and Parkinson disease as tracer conditions, the report highlights the wide unavailability and unaffordability of these medicines, explores the different health system barriers affecting access, and showcases special scenarios where some of the challenges can be exacerbated. The report offers a framework for multi-level, multi-sectoral actions to address the challenges identified, and serves as a call to action for all stakeholders to commit to tangible, sustainable improvements in the accessibility of medicines for neurological disorders. The WHO Brain Health Unit kindly invite you to join the virtual launch and support the dissemination of the findings of this important report. Please use the following link to register and feel free to share it within your networks: https://lnkd.in/e4fhazZ7

🥁 Did you know that countries investing in treating Multiple Sclerosis (MS) and other neurological disorders are not only improving health outcomes but also boosting their economies? Here's a report which serves a great example of it! Recent research highlights that neurological disorders, including MS, impose a substantial economic burden on the UK, costing approximately £96 billion annually. However, by implementing existing treatments and preventative measures, these costs can be significantly reduced. For example, optimizing care for neurological conditions could potentially save the UK economy over £30 billion each year by minimizing healthcare costs and improving productivity. Investing in comprehensive neurological care not only enhances the quality of life for millions but also drives economic growth by reducing the indirect costs associated with lost employment and caregiving responsibilities. Learn more about the impact and the call for a Neuro Taskforce to enhance care and support: The Value of Action: Mitigating the Impact of Neurological Disorders in the UK. https://lnkd.in/dxMKPfq7 Together, we can drive positive change and economic benefits by prioritizing neurological health! #HealthEconomics #Neurology #MultipleSclerosis #HealthcareInvestment #EconomicGrowth

I am deeply curious about exploring holistic approaches to managing chronic diseases and how far medical research has advanced. Let’s look at Crohn's disease. I know someone who struggled with Crohn's, and unfortunately, their journey did not end well.  However, I also know others who have managed to live fulfilling lives despite the condition. ⏩ What is Crohn's Disease? Crohn's disease is a chronic inflammatory condition of the gastrointestinal (GI) tract. It can affect any part of the GI tract, causing symptoms like abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. Despite being identified in the early 20th century, it remains relatively "new" in terms of understanding its full complexity and finding a cure. ⏩ Medical advancements. How far has medicine progressed in researching Crohn's disease? There have been significant advancements in understanding its genetic, environmental, and immunological factors. Treatments have improved, focusing on reducing inflammation, managing symptoms, and achieving remission. Researchers are continually exploring new therapies, including biological treatments that target specific components of the immune system. ⏩ Scientific research. While there is no definitive proof that stress or emotional problems directly cause Crohn's disease, research shows that they can exacerbate symptoms. This highlights the importance of a holistic approach that includes managing stress and emotional well-being alongside medical treatment. While this is a personal perspective, I believe that psychosomatics plays a crucial role in Crohn's disease. The gut, often referred to as the "second brain" due to its vast network of nerve endings, is closely connected with our emotions and mental state. It is possible that the mind-body connection is more significant than currently understood, and further research is needed to fully uncover this relationship. #Health #Healthcare #CrohnsDisease #MedicalResearch #MindBodyConnection #Psychosomatics #HealthcareInnovation

#CBD #dementia For vascular dementia (which results from lowered blood flow to the brain), 300 mg of CBD per day helped these elderly patients on their scores of psychological & behavioral symptoms. Today's paper: 'Effects of cannabidiol on behavioral and psychological symptoms of vascular dementia: a randomized, double-blind, placebo-controlled trial' https://lnkd.in/eqGqa3kE For more studies, see the 'Alzheimer's Disease & Dementia' page on CVResearch.info: https://lnkd.in/eGXXqWxe As always, thanks to CV Sciences, Inc. for sponsoring this canna-education video series. #vasculardementia #aging #brainhealth #agingbrain #elderlyhealth

Alzheimer’s disease is a progressive neurodegenerative disorder, marked by the build-up of amyloid plaques and tau tangles in the brain. These changes lead to cognitive decline and memory loss, significantly impacting the lives of millions. While there’s currently no cure, innovative treatments are on the horizon. Recent research highlights a promising approach: 40 Hz gamma wave sensory intervention. This cutting-edge technique could potentially manage symptoms and slow the progression of AD. 🔗 Dive into the latest findings and explore how this novel intervention could change the future of AD treatment. https://lnkd.in/gQNpvepR #VFDementia #DementiaFree #AlzheimersAwareness #40HZ #GammaWaves #CognitiveHealth

How Living Health Integrative Medicine treats Neuropathy First, we must find the cause of your nerve damage. The next step is a comprehensive neurological evaluation to determine which specific nerve fibers are damaged and the severity of that damage. Not every cause of neuropathy is the same, so every patient’s treatment plan is not the same but designed for their cause and condition. If you or someone you know has been diagnosed with neuropathy, or are currently experiencing any symptoms, don’t wait until it’s too late. If there is damage to the peripheral nerves occurring, the earlier treatment is started the easier it is to correct. If you are ready to take the first step to correcting your nerves click the link below to watch our Neuropathy Solutions Webinar. https://ow.ly/iNH450TRawS

How Living Health Integrative Medicine treats Neuropathy First, we must find the cause of your nerve damage. The next step is a comprehensive neurological evaluation to determine which specific nerve fibers are damaged and the severity of that damage. Not every cause of neuropathy is the same, so every patient’s treatment plan is not the same but designed for their cause and condition. If you or someone you know has been diagnosed with neuropathy, or are currently experiencing any symptoms, don’t wait until it’s too late. If there is damage to the peripheral nerves occurring, the earlier treatment is started the easier it is to correct. If you are ready to take the first step to correcting your nerves click the link below to watch our Neuropathy Solutions Webinar. https://ow.ly/NCwo50TRawQ

We are thrilled to announce our latest publication, "Treatment of Parkinson's Disease Psychosis—A Systematic Review and Multi-Methods Approach," in Biomedicines 🎉📖. Our research explores current treatment options for Parkinson's Disease Psychosis (PDP), evaluating their efficacy and highlighting challenges in management 🧠💊. 🔍 Key Highlights: · 📊 Comprehensive analysis of PDP treatments. · 🩺 Insights from specialized PD clinicians. · 🧑⚕️ Aiming for improved patient-centered care. In conclusion, the reviewed literature and survey results strongly support clozapine as the first-line treatment for PDP due to its efficacy and tolerability, while pimavanserin serves as a viable alternative option 💡✅. #ParkinsonsDisease #Psychosis #Research #Healthcare #PMU

Patellofemoral pain (PFP) is a surprisingly common condition, especially in adolescents, with more than 1/4 of them affected. If you think it’s just a fleeting issue, think again—about 40-56% of people who undergo treatment still report symptoms one to two years later.   This persistence makes PFP a condition that deserves serious attention from researchers, clinicians, and patients alike. What’s even more concerning is that PFP doesn’t just go away. There’s growing evidence that experiencing PFP during the younger years can increase the risk of developing patellofemoral joint (PFJ) osteoarthritis later in life.   Osteoarthritis is a chronic condition that can cause pain, reduced mobility, and even psychological issues like anxiety and depression. So, while PFP might start as a frustrating ache, it has the potential to ripple out into far more significant health challenges if not managed effectively. ----- I break down sports medicine research, give fun infographics and clinical tips in my weekly newsletter: Full study breakdown Tomorrow! Get The Breakdown --> https://lnkd.in/eeqWt2TF Study: Stephen, J., Ephgrave, C., Ball, S. and Church, S., 2020. Current concepts in the management of patellofemoral pain—the role of alignment. The Knee, 27(2), pp.280-286.

As we embrace the warmth of June and the longest day of the year, let’s shine a spotlight on Alzheimer’s And Brain Health. This month, we unite to raise awareness about Alzheimer’s disease and its impact on millions of lives. Alzheimer's and Brain Awareness Month serves as an opportunity to educate ourselves, support those affected by the disease, and take proactive steps to maintain optimal brain health. Whether you’ve personally experienced its effects or care for someone who has, Alzheimer’s touches us all. Here are some symptoms of Alzheimer’s disease on the photo below. For more information visit https://lnkd.in/gJau8eDF. If you or a loved ones are experiencing any of theses symptoms please seek a doctor. Early diagnosis gives you a chance to seek a treatment plan. And if you or a loved one need assistance in finding the right home or need guidance with the next steps, please give us a call at 586-310-3200. Share this to raise awareness about Alzheimer’s disease. Let’s support those affected and promote early detection. CarePlanners, your healthcare connection.